Skip to main content

Advertisement

Log in

The influence of xerostomia after radiotherapy on quality of life

Results of a questionnaire in head and neck cancer

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Introduction

Xerostomia is a common complication of radiotherapy for head and neck cancer because irreparable damage is caused to the salivary glands if they are included in the radiation fields. The aim of the study was to evaluate the degree of xerostomia in survivors of head and neck cancer and to determine its impact on quality of life.

Methods and materials

A xerostomia questionnaire consisting of three parts (xerostomia score, quality of life survey, and visual analogue scale) was completed by 75 head and neck cancer patients, more than 6 months after radiotherapy and without evidence of disease.

Results

The majority of patients (93%) suffered from a dry mouth, and 65% had moderate to severe xerostomia (grade 2 to 3). Both dysphagia (65%) and taste loss (63%) were common, although oral pain was less frequent (33%). The emotional impact of xerostomia was significant, causing worry (64%), tension (61%), or feelings of depression (44%). Furthermore, patients reported problems with talking to (60%) or eating with (54%) other people and to feel restricted in amount and type of food (65%). Quality of life was influenced by T classification, clinical stage, a higher radiation dose or the use of concomitant chemotherapy, but was independent of the interval since the end of radiotherapy.

Conclusions

Xerostomia after radiotherapy for head and neck cancer is extremely common and significantly affects quality of life. No recuperation is seen over time, and the use of concomitant chemotherapy significantly increases the oral complications of radiation. These results warrant the continuing efforts put into the development of salivary gland-sparing radiotherapy techniques and effective treatments of radiation-induced xerostomia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bjordal K, Kaasa S, Mastekaasa A (1994) Quality of life in patients treated for head and neck cancer. Int J Radiat Oncol Biol Phys 28:847–856

    PubMed  CAS  Google Scholar 

  2. Bjordal K, Freng A, Thorvik J, Kaasa S (1995) Patient self-reported and clinician-rated quality of life in head and neck cancer patients: a cross-sectional study. Oral Oncol 31:235–241

    Google Scholar 

  3. Braam PM, Roesink JM, Moerland MA et al (2005) Long-term parotid gland function after radiotherapy. Int J Radiat Oncol Biol Phys 62:659–664

    Article  PubMed  Google Scholar 

  4. Braam PM, Roesink JM, Raaijmakers C, Busschers W, Terhaard C (2007) Quality of life and salivary output in patients with head-and-neck cancer five years after radiotherapy. Radiat Oncol 2:3

    Article  PubMed  Google Scholar 

  5. Bussels B, Maes A, Flamen P et al (2004) Dose–response relationships within the parotid gland after radiotherapy for head and neck cancer. Radiother Oncol 73:297–306

    Article  PubMed  Google Scholar 

  6. Dirix P, Nuyts S, Van den Bogaert W (2006) Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer 107(11):2525–2534

    Article  PubMed  Google Scholar 

  7. Dirix P, Nuyts S, Vander Poorten V, Van den Bogaert W (2007) Efficacy of the BioXtra dry mouth care system in the treatment of radiotherapy-induced xerostomia. Support Care Cancer (in press; E-pub ahead of print)

  8. Duncan GG, Epstein JB, Tu D, El Sayed S, Bezjak A, Ottaway J, Pater J (2005) Quality of life, mucositis and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucostis. Head Neck 27:421–428

    Article  PubMed  Google Scholar 

  9. Eisbruch A, Rhodus N, Rosenthal D et al (2003) How should we measure and report radiotherapy-induced xerostomia? Semin Radiat Oncol 13:226–234

    Article  PubMed  Google Scholar 

  10. Eisbruch A, Terrell JE (2003) Letters to the editor. Head Neck 25:1082–1083

    Article  PubMed  Google Scholar 

  11. Epstein JB, Emerton S, Kolbinson DA et al (1999) Quality of life and oral function following radiotherapy for head and neck cancer. Head Neck 21:1–11

    Article  PubMed  CAS  Google Scholar 

  12. Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P (2001) Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 23:389–398

    Article  PubMed  CAS  Google Scholar 

  13. Guchelaar H, Vermes A, Meerwaldt JH (1997) Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer 5:281–288

    Article  PubMed  CAS  Google Scholar 

  14. Harrison L, Zelefski M, Pfitzer D et al (1997) Detailed quality of life assessment in patients treated with primary radiotherapy for cancer of the base of tongue. Head Neck 19:169–175

    Article  PubMed  CAS  Google Scholar 

  15. Hassan SJ, Weymuller EA (1993) Assessment of quality of life in head and neck cancer patients. Head Neck 15:485–496

    Article  PubMed  CAS  Google Scholar 

  16. Henk JM (1997) Controlled trials of synchronous chemotherapy with radiotherapy in head and neck cancer: overview of radiation morbidity. Clin Oncol 9:308–312

    Article  CAS  Google Scholar 

  17. Hoopman R, Muller MJ, Terwee CB, Aaronson NK (2006) Translation and validation of the EORTC QLQ-C30 for use among Turkish and Moroccan ethnic minority cancer patients in the Netherlands. Eur J Cancer 42(12):1839–1847

    Article  PubMed  CAS  Google Scholar 

  18. Jemal A, Siegel R, Ward E et al (2006) Cancer statistics. CA Cancer J Clin 56:106–130

    Article  PubMed  Google Scholar 

  19. Long SA, D’Antonio LL, Robinson EB, Zimmerman G, Petti G, Chonkich G (1996) Factors related to quality of life and functional status in 50 patients with head and neck cancer. Laryngoscope 106:1084–1088

    Article  PubMed  CAS  Google Scholar 

  20. Maes A, Weltens C, Flamen P et al (2002) Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother Oncol 63:203–211

    Article  PubMed  Google Scholar 

  21. Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C, Eisbruch A (2006) Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys 66(2):445–453

    PubMed  Google Scholar 

  22. Meyer TK, Kuhn JC, Campbell BH et al (2004) Speech intelligibility and quality of life in head and neck survivors. Laryngoscope 114:1977–1981

    Article  PubMed  Google Scholar 

  23. Nieuw Amerongen AV, Veerman ECI (2003) Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 11:226–231

    PubMed  CAS  Google Scholar 

  24. Roesink J, Schipper M, Busschers W, Raaijmakers C, Terhaard C (2005) A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: implications for future trials. Int J Radiat Oncol Biol Phys 63:1006–1009

    Article  PubMed  Google Scholar 

  25. Thoeny H, De Keyzer F, Claus F, Sunaert S, Hermans R (2005) Gustatory stimulation changes the apparent diffusion coefficient of salivary glands: initial experience. Radiology 235:629–634

    Article  PubMed  Google Scholar 

  26. Van Acker F, Flamen P, Lambin P et al (2001) The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapy. Nucl Med Common 22:225–231

    Article  Google Scholar 

  27. Weymuller EA, Yueh B, Deleyiannis F et al (2000) Quality of life in head and neck cancer. Laryngoscope 110(Suppl 94):4–7

    Article  PubMed  Google Scholar 

  28. Weymuller EA, Yueh B, Deleyiannis F et al (2000) Quality of life in patients with head and neck cancer. Lessons learned from 549 prospectively evaluated patients. Arch Otolaryngol Head Neck Surg 126:329–335

    PubMed  CAS  Google Scholar 

  29. Wijers O, Levendag P, Braaksma M, Boonzaaijer M, Visch L, Schmitz P (2002) Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors. Head Neck 24:737–747

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

This work was supported by grants from the Vlaamse Liga tegen Kanker (VLK) and the Klinisch Onderzoeksfonds (KOF).

Conflict of interest

All authors have read and approved the manuscript; we have no conflicts of interest to declare or financial support from industry sources to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Piet Dirix.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dirix, P., Nuyts, S., Vander Poorten, V. et al. The influence of xerostomia after radiotherapy on quality of life. Support Care Cancer 16, 171–179 (2008). https://doi.org/10.1007/s00520-007-0300-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-007-0300-5

Keywords

Navigation